Biocartis

Biocartis aims to improve quality of life by enabling direct access to personalized medicine to patients worldwide. Its goal is to advance medical treatment through the broad implementation of state-of-the-art diagnostic tests performed close to the clinical decision-making point. 

Biocartis' innovative research and diagnostic systems feature the detection of molecular components, which are indicative for a specific pathological state. The new systems are highly user-friendly, require less hands-on time and minimize the handling of valuable samples, which is of the utmost importance for tumor biopsies. In addition, Biocartis develops assays with major clinical and compelling health economic value. Oncology is Biocartis' primary focus as it represents one of the areas with the highest unmet needs for personalized medicine. 

Biocartis is a rapidly growing company that currently employs close to 200 people. It has offices in Belgium (close to Brussels) and in Switzerland (Lausanne).